Idioma:

The logic of strategic ignorance

McGoey, Linsey

The British journal of sociology, 2012-09, Vol.63 (3), p.533-576 [Periódico revisado por pares]

Oxford: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por

Enviar para

Título:
The logic of strategic ignorance
Autor: McGoey, Linsey
Assuntos: Anti-Bacterial Agents - adverse effects ; Antibiotics ; Commerce ; Constraints ; Crises ; Drug and Narcotic Control - legislation & jurisprudence ; Drugs ; Failure ; FDA approval ; Federal regulation ; Food ; General studies ; Humans ; Ketolides - adverse effects ; Knowledge ; knowledge alibis ; Liability ; Liver diseases ; Manufacturing ; Organization theory ; pharmaceuticals ; Political authority ; Political Power ; Politics ; power ; Power (Psychology) ; Prescription drugs ; Product safety ; Regulation ; regulatory failure ; Safety ; Side effects ; Social organization. Social system. Social structure ; Social Responsibility ; Sociology ; Sociology of ignorance ; Sociology of knowledge ; Sociology of knowledge and ethics ; Sociology of knowledge and sociology of culture ; Sociology of organizations and enterprises. Bureaucracy and administration ; Sociology of work and sociology of organizations ; Studies ; United Kingdom ; United States ; Values
É parte de: The British journal of sociology, 2012-09, Vol.63 (3), p.533-576
Notas: ark:/67375/WNG-W4RNBX8L-D
Many thanks to Eamonn Carrabine, Nicolas Guilhot, Peter Jacobson, Lisa Stampnitzky, Catherine Will and Scott Vrecko for comments on the article. My analysis of the Ketek case has been enhanced through discussions with members of the Pharmaceutical Dissent project, Kate Weiner, Sujatha Raman, and Catherine Will, as well as research assistance on Ketek from Shadreck Mwale. This article was written through the support of a James Martin fellowship in science and technology studies at the University of Oxford, as well as a visiting fellowship at the Brocher Foundation, Geneva. Thanks to the Oxford STS group, past and present, in particular Noortje Marres and Tanja Schneider.
istex:69C53C2ADE87AFC506FBA561A7936A6834DBE23C
ArticleID:BJOS1424
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Descrição: Ignorance and knowledge are often thought of as opposite phenomena. Knowledge is seen as a source of power, and ignorance as a barrier to consolidating authority in political and corporate arenas. This article disputes this, exploring the ways that ignorance serves as a productive asset, helping individuals and institutions to command resources, deny liability in the aftermath of crises, and to assert expertise in the face of unpredictable outcomes. Through a focus on the Food and Drug Administration's licensing of Ketek, an antibiotic drug manufactured by Sanofi‐Aventis and linked to liver failure, I suggest that in drug regulation, different actors, from physicians to regulators to manufacturers, often battle over who can attest to the least knowledge of the efficacy and safety of different drugs – a finding that raises new insights about the value of ignorance as an organizational resource.
Editor: Oxford: Blackwell Publishing Ltd
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

The logic of strategic ignorance

McGoey, Linsey

Oxford: Blackwell Publishing Ltd

Buscando em bases de dados remotas. Favor aguardar.